Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Prohibix LLC has 1 pending office action currently active. This prosecution is handled by 1 distinct examiner, CHO, DAVID H. The data shows that 0 distinct art units are associated with this portfolio, indicating a unique administrative status for the current pending matter.
The busiest examiner, CHO, DAVID H, is responsible for 1 busiest examiner pending action. This matches the total volume of 1 pending action for the company. Because the portfolio is concentrated under 1 distinct examiner, the prosecution strategy is focused on a single point of contact. This centralized workload means that the progress of the company's current patent application relies solely on the review of CHO, DAVID H, with no other examiners or art units currently involved.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CHO, DAVID H | 1 | 31.9% | +67.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18701138 | CROSSLINKED HYALURONIC ACID PRECIPITATES | CHO, DAVID H | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18701138 | CROSSLINKED HYALURONIC ACID PRECIPITATES | CHO, DAVID H | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18701138 | CROSSLINKED HYALURONIC ACID PRECIPITATES | CHO, DAVID H | — | §101§103§112 | Non-Final OA | — | Pending | Apr 12, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial